An exploration of prevalence and associated factors of nonalcoholic fatty liver disease in the Taiwanese police service

Iranian Journal of Public Health

Volumn 40, Issue 4, 2011, Pages 54-62

  Tung, T H ^a,b   Chiu, W H ^a,c,d,e   Lin, T H ^a,b   Shih, H C ^f   Hsu, C T ^a  

^a CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d Central Clinic and Hospital   (Taiwan)

^e Chung Shan Hospital   (Taiwan)

^f KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

Gender difference; Nonalcoholic fatty liver disease; Police service; Prevalence

Indexed keywords

EID: 84255190191     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Baumeister SE, Volzke H, Marschall P, John U, Schmidt CO, Flessa S, et al (2008). Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation. Gastroenterology, 134 (1): 85-94.
2. Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE (2008). Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther, 28 (1): 13-24.
3. Williams R (2006). Global changes in liver disease. Hepatology, 44 (3): 521-26.
4. Angulo P (2007). GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther, 25 (8): 883-89.
5. Su CC, Wang K, Hsia TL, Chen CS, Tung TH (2006). Association of nonalcoholic fatty liver disease with abnormal aminotransferase and postprandial hyperglycemia. J Clin Gastroenterol, 40 (6): 551-54.
6. Brunt EM (2004). Nonalcoholic steatohepatitis. Semin Liver Dis, 24 (1): 3-20.
7. Sheth SG, Gordon FD, Chopra S (1997). Nonalcoholic steatohepatitis. Ann Intern Med, 126 (2): 137-45.
8. Berg AM, Hem E, Lau B, Ekeberg Ø (2006). An exploration of job stress and health in the Norwegian police service: a cross sectional study. J Occup Med Toxicol, 1: 26.
9. Liu CM, Tung TH, Liu JH, Chen VT, Lin CH, Hsu CT, Chou P (2005). A commumitybased epidemiological syudy of elevated serum alanine aminotransferase levels in Kinmen, Taiwan. World J Gastroenterol, 11 (11): 1616-22.
10. Dai HF, Shen Z, Yu CH, Zhang XC, Li YM (2008). Epidemiology of fatty liver in an islander population of China: a populationbased case-control study. Hepatobiliary Pancreat Dis Int, 7 (4): 373-78.
11. Lazo M, Clark JM (2008). The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis, 28 (4): 339-50.
12. Fan JG, Farrell GC (2009). Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol, 50 (1): 204-10.
13. Zhou YJ, Li yy, Nie YQ, Ma JX, Lu LG, Shi SL, et al (2007). Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol, 13 (47): 6419-24.
14. Fan JG, Zhu j, Li XJ, Chen L, Li L, Dai F, et al (2005). Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol, 43 (3): 508-14.
15. Carulli L, Lonardo A, Lombardini S, Marchesini G, Loria P (2006). Gender, fatty liver and GGT. Hepatology, 44 (1): 278-79.
16. Pratt DS, Kaplan MM (2000). Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med, 342 (17): 1266-71.
17. Fan JG, Li f, Cai XB, Peng YD, Ao QH, Gao Y (2007). The important of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. J Gastroenterol Hepatol, 22 (5): 663-68.
18. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al (2007). Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol, 22 (9): 1482-89.
19. Alberti KG, Zimmet P, Shaw J (2006). Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 23 (5): 469-80.
20. Fan JG, Peng YD (2007). Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat Dis Int, 6 (6): 572-78.
21. Huang HL, Lin WY, Lee LT, Wang HH, Lee WJ, Huang KC (2007). Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects. Obes Surg, 17 (11): 1457-63.
22. Fan JG, Zhu J, Li XJ, Chen L, Lu YS, Li L, et al (2005). Fatty liver and the metabolic syndrome among Shanghai adults. J Gartroenterol Hepatol, 20 (12): 1825-32.
23. Loguercio C, Nardone G, Sicolo P, Cuomo R, Del Vecchio C, Budillon G (1996). Intravenous load of fructose and fructose 1,6- diphosphate: effects on uricemia in patients with nonalcoholic liver disease. Am J Gastroenterology, 91 (3): 559-64.
24. Bruckert E, Giral P, Ratziu V, Poynard T, Chapman MJ, Opolon P, Turpin G (2002).A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients. Metabolism, 51 (8): 1071-76.